Trial Profile
Phase I/II study of tolerogenic vaccine
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Vaccines (Primary)
- Indications Haemophilia A
- Focus Adverse reactions; First in man
- 30 Dec 2016 New trial record
- 14 Dec 2016 According to an Idogen media release, company had a successful scientific advice meeting with the Swedish Medical Products Agency regarding the proposed design of this study.